Riskpilot← Back to searchSign inGet full accessACB Holding AB
ABIn liquidationOrg 5591195762Economic activity was not specified by tax authority · NACE 0000Est. 20170 employees
Revenue 2022
SEK 0
EBITDA margin
—
-168% vs 2021
Equity ratio
-1725.8%
Financial strength
Net profit 2022
SEK -3,1M
-157% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -3,1M | -168% |
| Net profit | SEK -3,1M | -157% |
| Total assets | SEK 229K | -27% |
| Equity | SEK -4M | -341% |
| Employees | 0 | — |
Legal name
ACB Holding AB
Org number
5591195762
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
14 juli 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-04-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Föremålet för bolagets verksamhet är att direkt och indirekt driva forsknings- och utvecklingsarbete inom det biomedicinska området, med särskild inriktning på krillenzymer, samt inneha rätt till sådana produkter, tillverka och försälja dem i hela världen, samt idka därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −13 | −342 | −68 | −1 141 | −3 056 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −13 | −342 | −68 | −1 141 | −3 056 |
| Net financials | — | — | 665 | −46 | — |
| Profit before tax | −13 | −342 | 597 | −1 188 | −3 056 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 | −342 | 597 | −1 188 | −3 056 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 50 | 918 | 922 | 315 | 229 |
| Equity | 37 | −305 | 292 | −896 | −3 952 |
| Long-term debt | 0 | 661 | 0 | 0 | 0 |
| Short-term debt | 13 | 562 | 629 | 1 210 | 4 181 |
| Total debt | 13 | 1 223 | 629 | 1 210 | 4 181 |
EBITDA margin
-305600000.0%
This company
15.8%
Market median
-1934177315% vs market
20182022
Equity ratio
-1725.8%
This company
38.2%
Market median
-4618% vs market
20182022
Return on equity
-305600000.0%
This company
18.4%
Market median
-1660869665% vs market
20182022
Net profit margin
-305600000.0%
This company
8.1%
Market median
-3772839606% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Liquidator | Liquidator | 2022 |
| Former (1) | ||
FJ Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ACB Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fernando Junge | Chief Executive Officer | 0 companies |
| Madeleine E C H Ericson | Liquidator | 0 companies |
| Ricardo Fuad Majluf Sapag | Deputy Board Member | 0 companies |
| Curt Benny Michael Nyman | Deputy Board Member | 0 companies |
| Marcos Nicolaides | Board of Directors | 0 companies |
| Sten Lennart Sjöstedt | Deputy Board Member | 0 companies |
| Max Rutman | Chairman | 0 companies |